Journal of Internal Medicine Concepts & Practice ›› 2023, Vol. 18 ›› Issue (03): 221-224.doi: 10.16138/j.1673-6087.2023.03.018
• Review article • Previous Articles
SU Zhengjia, XIANG Xiaogang, LIANG Qiuli, et al
Received:2022-08-25
Online:2023-06-30
Published:2023-08-07
CLC Number:
SU Zhengjia, XIANG Xiaogang, LIANG Qiuli, et al . Research progress of interleukin⁃37 effect on cardiovascular diseases[J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(03): 221-224.
| [1] |
Rafiei A, Ahmadi R, Kazemian S, et al. Serum levels of IL-37 and correlation with inflammatory cytokines and clinical outcomes in patients with coronary artery disease[J]. J Investig Med, 2022, 70(8): 1720-1727.
doi: 10.1136/jim-2021-002134 URL |
| [2] |
Jia C, Zhuge Y, Zhang S, et al. IL-37b alleviates endothelial cell apoptosis and inflammation in Kawasaki disease through IL-1R8 pathway[J]. Cell Death Dis, 2021, 12(6): 575.
doi: 10.1038/s41419-021-03852-z pmid: 34083516 |
| [3] |
Nold-Petry CA, Nold MF. Rationale for IL-37 as a novel therapeutic agent in inflammation[J]. Expert Rev Clin Immunol, 2022, 18(12): 1203-1206.
doi: 10.1080/1744666X.2022.2108792 URL |
| [4] |
Qin YF, Ren SH, Shao B, et al. The intellectual base and research fronts of IL-37: a bibliometric review of the literature from WoSCC[J]. Front Immunol, 2022, 13: 931783.
doi: 10.3389/fimmu.2022.931783 URL |
| [5] |
Yang Z, Kang L, Wang Y, et al. Role of IL-37 in cardiovascular disease inflammation[J]. Can J Cardiol, 2019, 35(7): 923-930.
doi: S0828-282X(19)30268-5 pmid: 31292092 |
| [6] |
Su Z, Tao X. Current understanding of IL-37 in human health and disease[J]. Front Immunol, 2021, 12: 696605.
doi: 10.3389/fimmu.2021.696605 URL |
| [7] |
Zhuang X, Wu B, Li J, et al. The emerging role of interleukin-37 in cardiovascular diseases[J]. Immun Inflamm Dis, 2017, 5(3): 373-379.
doi: 10.1002/iid3.159 URL |
| [8] |
Lotfy H, Moaaz M, Moaaz M. The novel role of IL-37 to enhance the anti-inflammatory response of regulatory T cells in patients with peripheral atherosclerosis[J]. Vascular, 2020, 28(5): 629-642.
doi: 10.1177/1708538120921735 pmid: 32366176 |
| [9] | 陈少源, 方红城, 黄于朗, 等. 白细胞介素37/Smad3在兔腹主动脉粥样硬化斑块中的表达研究[J]. 中国心血管杂志, 2019, 24(2): 161-165. |
| [10] | 朱静和, 钱雷, 蒋凤, 等. 白细胞介素37对动脉粥样硬化患者单核巨噬细胞脂蛋白相关磷脂酶A2的抑制作用[J]. 中华老年心脑血管病杂志, 2020, 22(8): 873-875. |
| [11] |
Liu J, Lin J, He S, et al. Transgenic overexpression of IL-37 protects against atherosclerosis and strengthens plaque stability[J]. Cell Physiol Biochem, 2018, 45(3): 1034-1050.
doi: 10.1159/000487344 pmid: 29439249 |
| [12] |
Liu K, Tang Q, Zhu X, et al. IL-37 increased in patients with acute coronary syndrome and associated with a worse clinical outcome after ST-segment elevation acute myocardial infarction[J]. Clin Chim Acta, 2017, 468: 140-144.
doi: S0009-8981(17)30069-4 pmid: 28237549 |
| [13] | Liu C, Cui Y, Zhang D, et al. Analysis of serum interleukin-37 level and prognosis in patients with ACS[J]. Comput Math Methods Med, 2021, 2021:3755458. |
| [14] |
McCurdy S, Yap J, Irei J, et al. IL-37-a putative therapeutic agent in cardiovascular diseases[J]. QJM, 2022, 115(11): 719-725.
doi: 10.1093/qjmed/hcab011 URL |
| [15] |
Yang T, Fang F, Chen Y, et al. Elevated plasma interleukin-37 playing an important role in acute coronary syndrome through suppression of ROCK activation[J]. Oncotarget, 2017, 8(6): 9686-9695.
doi: 10.18632/oncotarget.14195 pmid: 28039466 |
| [16] |
Li X, Hu H, Guo D, et al. Imbalance of pro- and anti-inflammatory cytokines induced different types of recurrent atrial arrhythmias after drug eluting coronary stent implantation[J]. Curr Vasc Pharmacol, 2022, 20(5): 447-456.
doi: 10.2174/1570161120666220831094507 pmid: 36045517 |
| [17] | Mao X, Zhu R, Zhang F, et al. IL-37 plays a beneficial role in patients with acute coronary syndrome[J]. Mediators Inflamm, 2019, 2019: 9515346. |
| [18] | Zhu R, Zhang F, Pan C, et al. Role of IL-37- and IL-37-treated dendritic cells in acute coronary syndrome[J]. Oxid Med Cell Longev, 2021, 2021: 6454177. |
| [19] | Shou X, Lin J, Xie C, et al. Plasma IL-37 elevated in patients with chronic heart failure and predicted major adverse cardiac events[J]. Dis Markers, 2017, 2017: 9134079. |
| [20] | 曲延成, 杨赞. 慢性心力衰竭患者心功能与血浆IL-18、IL-37及IL-33的相关性研究[J]. 贵州医药, 2018, 42(6): 659-661. |
| [21] | 王毅, 陈海潮, 林静, 等. 慢性心力衰竭患者血浆白介素-37水平变化研究[J]. 临床医学研究与实践, 2019, 4(5): 93-95. |
| [22] |
de Sanctis JB. Innate immune response in hypertension[J]. Curr Pharm Des, 2022, 28(36): 2984-2990.
doi: 10.2174/1381612828666220922112412 URL |
| [23] |
Ye J, Wang Y, Wang Z, et al. Circulating IL-37 levels are elevated in patients with hypertension[J]. Exp Ther Med, 2021, 21(6): 558.
doi: 10.3892/etm.2021.9990 pmid: 33850530 |
| [24] | 胡耀明, 雷慧娟. IL-6、IL-18与心房颤动的关系研究[J]. 实用中西医结合临床, 2019, 19(8): 1-2. |
| [25] |
Li W, Li S, Li X, et al. Interleukin-37 elevation in patients with atrial fibrillation[J]. Clin Cardiol, 2017, 40(2): 66-72.
doi: 10.1002/clc.22630 pmid: 28244597 |
| [26] |
Li J, Zhang WJ, Yao H, et al. Therapeutic effects of interleukin-37 and induced cardiosphere on treating myocardial ischemia-reperfusion injury[J]. Int Immunopharmacol, 2020, 88:106719.
doi: 10.1016/j.intimp.2020.106719 URL |
| [27] |
Wang YM, Zhang JJ, Wu BW, et al. IL-37 improves mice myocardial infarction via inhibiting YAP-NLRP3 signaling mediated macrophage programming[J]. Eur J Pharmacol, 2022, 934:175293.
doi: 10.1016/j.ejphar.2022.175293 URL |
| [28] |
López-Bautista F, Posadas-Sánchez R, Vázquez-Vázquez C, et al. IL-37 gene and cholesterol metabolism: association of polymorphisms with the presence of hypercholesterolemia and cardiovascular risk factors[J]. Biomolecules, 2020, 10(10): 1409.
doi: 10.3390/biom10101409 URL |
| [29] | López-Bautista F, Posadas-Sánchez R, Vargas-Alarcón G. Association of the IL-37 polymorphisms with transaminases and alkaline phosphatase levels in premature coronary artery disease patients and healthy controls[J]. Diagnostics (Basel), 2021, 11(6): 1018. |
| [30] |
Yin D, Naji DH, Xia Y, et al. Genomic variant in IL-37 confers a significant risk of coronary artery disease[J]. Sci Rep, 2017, 7: 42175.
doi: 10.1038/srep42175 pmid: 28181534 |
| [1] | HU Jiaojiao, XU Jinpeng, LIU Huiguang. Angina pectoris caused by right coronary artery originated from left anterior descending artery: a case report [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(03): 190-191. |
| [2] | PAN Roubai, ZONG Xiao, TAO Rong. Effect of probiotics on ventricular remodeling [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(02): 131-134. |
| [3] | MA Mengzhen, GONG Huanhuan, WANG Qin, ZHOU Fang. Inflammation mediate correlation of body mass index and arteriosclerosis [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(02): 83-86. |
| [4] | JIN Wei, YANG Chendie, WANG Lingjie, et al. Recommendations on diagnosis and treatment of myocarditis associated with novel coronavirus infection [J]. Journal of Internal Medicine Concepts & Practice, 2023, 18(01): 5-9. |
| [5] | LI Yongde, WANG Yang, LI Xiang, LI Wenjie, XIE Di, JIANG Shaowei, GE Xiaoli, WANG Hairong, GAO Chengjin, PAN Shuming. A retrospective study on prediction of neurological outcome in cardiac arrest patients of out-hospital [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(06): 447-452. |
| [6] | ZHANG Ruixin, QU Chunyan, JIANG Jie, TONG Jianjing. Analysis of knowledge depth and breadth of understanding chronic heart failure in general practitioners in Shanghai and influencing factors [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(06): 457-462. |
| [7] | WU Liqun. Greatness in simplicity—new technology of pulmonary vein isolation [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(05): 357-359. |
| [8] | LI Ruogu. Clinical application of His bundle pacing [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(05): 360-364. |
| [9] | TANG Baopeng, ZHANG Jianghua, GUO Yankai. Progress in clinical application of leadless pacemaker [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(05): 365-368. |
| [10] | LIU Ruifeng, SHENG Qianqian, ZHANG Yue, ZHAO Huiqiang. Lymphocyte and monocyte subtypes in coronary artery ectasia patients [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(05): 373-378. |
| [11] | YIN Xiang, ZHENG Liangrong. Research progress of percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(05): 392-395. |
| [12] | FEI Zhentao, CHEN Mu, LI Yigang. Research progress on mechanism of atrial fibrillation recurrence after catheter ablation [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(05): 396-399. |
| [13] | ZHANG Zhi, TANG Xuechao, HUANG Xinmiao, et al. Application of pulsed electric field ablation in atrial fibrillation [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(05): 400-404. |
| [14] | YANG Ling, ZHA Qing, ZHANG Qianru, YE Jiawen, YANG Ke, LIU Yan. Biomarker-based predictive model for calcific aortic valve disease [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(04): 324-329. |
| [15] | . [J]. Journal of Internal Medicine Concepts & Practice, 2022, 17(04): 337-338. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
